CN113804771B - 一种同时测定治疗肝病中药的多种成分含量的方法 - Google Patents
一种同时测定治疗肝病中药的多种成分含量的方法 Download PDFInfo
- Publication number
- CN113804771B CN113804771B CN202010551057.6A CN202010551057A CN113804771B CN 113804771 B CN113804771 B CN 113804771B CN 202010551057 A CN202010551057 A CN 202010551057A CN 113804771 B CN113804771 B CN 113804771B
- Authority
- CN
- China
- Prior art keywords
- mobile phase
- solution
- reference substance
- sample injection
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 34
- 208000019423 liver disease Diseases 0.000 title claims abstract description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 96
- 238000002347 injection Methods 0.000 claims abstract description 63
- 239000007924 injection Substances 0.000 claims abstract description 63
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 17
- 229960000583 acetic acid Drugs 0.000 claims abstract description 11
- 239000012362 glacial acetic acid Substances 0.000 claims abstract description 11
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 238000010828 elution Methods 0.000 claims abstract description 10
- 239000003643 water by type Substances 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims description 116
- 239000000523 sample Substances 0.000 claims description 68
- 239000013558 reference substance Substances 0.000 claims description 61
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 52
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 claims description 26
- 229940074391 gallic acid Drugs 0.000 claims description 26
- 235000004515 gallic acid Nutrition 0.000 claims description 26
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 claims description 26
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 25
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 25
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 claims description 24
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 claims description 24
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 claims description 24
- 238000005303 weighing Methods 0.000 claims description 24
- HYXITZLLTYIPOF-UHFFFAOYSA-N Tanshinone II Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 claims description 23
- 210000004185 liver Anatomy 0.000 claims description 23
- AZEZEAABTDXEHR-UHFFFAOYSA-M sodium;1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-2-sulfonate Chemical compound [Na+].C12=CC=C(C(CCC3)(C)C)C3=C2C(=O)C(=O)C2=C1OC(S([O-])(=O)=O)=C2C AZEZEAABTDXEHR-UHFFFAOYSA-M 0.000 claims description 23
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N tanshinone IIA Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 claims description 23
- 239000011550 stock solution Substances 0.000 claims description 13
- LLPWNQMSUYAGQI-OOSPGMBYSA-N notoginsenoside R1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)CO2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LLPWNQMSUYAGQI-OOSPGMBYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 239000012088 reference solution Substances 0.000 claims description 10
- 239000012159 carrier gas Substances 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 6
- 239000012488 sample solution Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 230000001502 supplementing effect Effects 0.000 claims description 5
- 238000009210 therapy by ultrasound Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 2
- LLPWNQMSUYAGQI-QBQUQATFSA-N Ginsenoside R1 Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)CO2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 LLPWNQMSUYAGQI-QBQUQATFSA-N 0.000 claims 5
- JURZHOVRCOWZFN-UHFFFAOYSA-N notoginsenoside R1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(COC7OCC(O)C(O)C7O)C(O)C(O)C6O)C JURZHOVRCOWZFN-UHFFFAOYSA-N 0.000 claims 5
- 239000012982 microporous membrane Substances 0.000 claims 1
- 238000005259 measurement Methods 0.000 abstract description 7
- 238000004451 qualitative analysis Methods 0.000 abstract description 2
- 238000004445 quantitative analysis Methods 0.000 abstract description 2
- 229930189092 Notoginsenoside Natural products 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229930182494 ginsenoside Natural products 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 244000131316 Panax pseudoginseng Species 0.000 description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 241001106477 Paeoniaceae Species 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- 229940107666 astragalus root Drugs 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 235000005412 red sage Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
成分 | 回归方程 | 线性范围(μg) | r |
没食子酸 | Y=2945.8X+4.5691 | 1.444~28.88 | 0.9999 |
葛根素 | Y=2362.3X+779.49 | 2.118~42.36 | 0.9998 |
丹参酮IIA | Y=403.14X+15.043 | 0.0667~1.334 | 0.9993 |
芍药苷 | Y=1.2469X+5.0060 | 1.074~21.48 | 0.9996 |
三七皂苷R1 | Y=1.2329X+6.1714 | 0.2180~4.360 | 0.9986 |
黄芪甲苷 | Y=1.1717X+5.3787 | 0.1151~2.302 | 0.9989 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010551057.6A CN113804771B (zh) | 2020-06-17 | 2020-06-17 | 一种同时测定治疗肝病中药的多种成分含量的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010551057.6A CN113804771B (zh) | 2020-06-17 | 2020-06-17 | 一种同时测定治疗肝病中药的多种成分含量的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113804771A CN113804771A (zh) | 2021-12-17 |
CN113804771B true CN113804771B (zh) | 2024-03-29 |
Family
ID=78943133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010551057.6A Active CN113804771B (zh) | 2020-06-17 | 2020-06-17 | 一种同时测定治疗肝病中药的多种成分含量的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113804771B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101837072A (zh) * | 2010-04-29 | 2010-09-22 | 贵州益康制药有限公司 | 一种治疗肝炎的药物制剂的质量检测方法 |
CN102539599A (zh) * | 2011-12-15 | 2012-07-04 | 石家庄东方药业有限公司 | 一种强肝药物的检测方法 |
CN105929080A (zh) * | 2016-06-16 | 2016-09-07 | 山东明仁福瑞达制药股份有限公司 | 一种治疗神经根型颈椎病的中药制剂的检测方法 |
-
2020
- 2020-06-17 CN CN202010551057.6A patent/CN113804771B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101837072A (zh) * | 2010-04-29 | 2010-09-22 | 贵州益康制药有限公司 | 一种治疗肝炎的药物制剂的质量检测方法 |
CN102539599A (zh) * | 2011-12-15 | 2012-07-04 | 石家庄东方药业有限公司 | 一种强肝药物的检测方法 |
CN105929080A (zh) * | 2016-06-16 | 2016-09-07 | 山东明仁福瑞达制药股份有限公司 | 一种治疗神经根型颈椎病的中药制剂的检测方法 |
Non-Patent Citations (3)
Title |
---|
HPLC-DAD法同时测定痛经丸中5种成分的含量;厉妲;张静;康廷国;;中药新药与临床药理(第03期);全文 * |
HPLC-DAD法同时测定黄芪护肝丸中5种活性成分的含量;米振清;刘斌;;中国现代中药(第11期);全文 * |
高效液相色谱法测定乙肝康颗粒中芍药苷、大黄素、丹参酮ⅡA的含量;刘彦;《中南药学》;第10卷(第7期);第512页-第513页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113804771A (zh) | 2021-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104764820A (zh) | 测定半夏糖浆中活性成分盐酸麻黄碱和盐酸伪麻黄碱含量的方法 | |
CN107402265B (zh) | 康媛颗粒指纹图谱的检测方法 | |
CN111089916B (zh) | 一种柴芍口服液中芍药苷、甘草苷和甘草酸铵含量的检测方法 | |
CN116008456A (zh) | 五神汤的指纹图谱检测方法 | |
CN103808835A (zh) | Hplc-dad法同时测定四物汤煎剂中10种化学成分含量的方法 | |
CN108037200B (zh) | 一种滋肾宁神丸的质量检测方法 | |
CN109856270A (zh) | 一种用高效液相色谱法同时测定华盖散配方颗粒中7个指标成分的方法 | |
CN108459129B (zh) | 一种防己茯苓汤组合物的质量控制方法 | |
CN112684036A (zh) | 黄蛭益肾胶囊指纹图谱测定方法及其应用 | |
CN113804771B (zh) | 一种同时测定治疗肝病中药的多种成分含量的方法 | |
CN109142563B (zh) | 一种龟龄集uplc指纹图谱的构建方法及其应用 | |
CN106290643A (zh) | 一种中药荆芥抗肺癌活性成分的质量控制方法 | |
CN114994220B (zh) | 一种七清败毒颗粒的指纹图谱的构建方法和其成分含量的测定方法及应用 | |
CN108333289B (zh) | 一种多组分检测控制蛴螬含量的方法 | |
CN116183805A (zh) | 一种桑菊感冒颗粒成分的检测和评价方法 | |
CN113447596B (zh) | 一种药物制剂中3种活性成分的测定方法 | |
CN114942291A (zh) | 潜阳育阴颗粒的质量检测方法 | |
CN110455948B (zh) | 一种头痛宁胶囊指纹图谱检测方法 | |
CN109781884B (zh) | 一种前列欣胶囊指纹图谱的建立方法及其指纹图谱 | |
CN113804773B (zh) | 一种治疗肝病中药指纹图谱的检测方法 | |
CN112924561B (zh) | 一种中药组合物中多指标成分的检测方法 | |
CN114965776B (zh) | 小儿黄龙颗粒的特征图谱的建立方法以及其标准特征图谱与应用 | |
CN113884585B (zh) | 正心降脂片的指纹图谱及其在质量控制中的应用 | |
CN115201389B (zh) | 九味补血口服液中药制剂的指纹图谱建立方法及指纹图谱 | |
CN117825600B (zh) | 一种基于一测多评法检测丹参注射液中间体各质量组分含量的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: 323000 No. 2 suisong Road, Lishui Economic Development Zone, Zhejiang Province Applicant after: ZHEJIANG WECOME PHARMACEUTICAL CO.,LTD. Applicant after: Yingkerui (Zhuhai Jinwan) Pharmaceutical Co.,Ltd. Address before: 323000 No. 2 suisong Road, Lishui Economic Development Zone, Zhejiang Province Applicant before: ZHEJIANG WECOME PHARMACEUTICAL CO.,LTD. Applicant before: Ying Kerui (Zhuhai) innovation Pharmaceutical Manufacturing Co.,Ltd. |
|
CB02 | Change of applicant information | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40068024 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant |